Allergan, Inc. (NYSE:AGN)

CAPS Rating: 4 out of 5

A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc.

Recs

0
Player Avatar NevDullNJ (< 20) Submitted: 2/8/2012 1:22:22 PM : Outperform Start Price: $89.02 AGN Score: +3.53

Many of Allergan's products are tied to the notion of "you, just better". As we're entering this "halftime in America" period, if we'll be doing better we'll want to feel better about ourselves, and AGN will be there to take our money.

Featured Broker Partners


Advertisement